French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

This is a French national registry following adult patients with immune thrombocytopenia (ITP) — a condition where the immune system destroys platelets, causing low platelet counts and easy bleeding — and autoimmune haemolytic anaemia (AIHA) — where the immune system attacks red blood cells. The registry also tracks patients starting fostamatinib, a new targeted medication for these conditions. You may be eligible if: - You are 18 years or older - You have been newly diagnosed with ITP or AIHA - OR you are starting fostamatinib treatment You may NOT be eligible if: - You object to having your data collected Talk to your doctor to see if this trial is right for you.